These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical Morphological Studies of Myelofibrosis with Different Types of Bone Marrow Involvement in Patients with Chronic Lymphocytic Leukemia. Dolgikh TY; Sholenberg EV; Kachesov IV; Domnikova NP; Klinnikova MG Bull Exp Biol Med; 2016 Jul; 161(3):408-11. PubMed ID: 27496034 [TBL] [Abstract][Full Text] [Related]
4. CD8 Yao Y; Li L; Yang SH; Gao CY; Liao LH; Xie YQ; Yin XY; Yang YQ; Fei YY; Lian ZX J Autoimmun; 2018 May; 89():101-111. PubMed ID: 29307587 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow hypervascularity in patients with myelofibrosis identified by infra-red thermography. Baglin TP; Crocker J; Timmins A; Chandler S; Boughton BJ Clin Lab Haematol; 1991; 13(4):341-8. PubMed ID: 1773587 [TBL] [Abstract][Full Text] [Related]
6. CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis. Tripodo C; Di Bernardo A; Ternullo MP; Guarnotta C; Porcasi R; Ingrao S; Gianelli U; Boveri E; Iannitto E; Franco G; Florena AM Haematologica; 2009 Jan; 94(1):127-30. PubMed ID: 19029148 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up. Ghanima W; Geyer JT; Lee CS; Boiocchi L; Imahiyerobo AA; Orazi A; Bussel JB Haematologica; 2014 May; 99(5):937-44. PubMed ID: 24463212 [TBL] [Abstract][Full Text] [Related]
8. [Pathological Characteristics of Bone Marrow in Multiple Myeloma Patients with Secondary Myelofibrosis and Their Relationship with Prognosis]. Zhao J; Ma L; Guan JH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1080-1085. PubMed ID: 28823272 [TBL] [Abstract][Full Text] [Related]
9. A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis. Hasselbalch H; Lisse I Eur J Haematol; 1991 May; 46(5):285-9. PubMed ID: 2044723 [TBL] [Abstract][Full Text] [Related]
10. [Pathological Characteristics of Bone Marrow in Non-Hodgkin's Lymphoma Patients with Secondary Myelofibrosis and Their Relationship with Prognosis]. Liu YL; Wang WJ; Wang XN Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):674-8. PubMed ID: 26117015 [TBL] [Abstract][Full Text] [Related]
11. A review of myelofibrosis in dogs. Reagan WJ Toxicol Pathol; 1993; 21(2):164-9. PubMed ID: 8210938 [TBL] [Abstract][Full Text] [Related]
12. Assessment of bone marrow and splenic erythropoiesis in myelofibrosis. Ferrant A; Rodhain J; Cauwe F; Cogneau M; Beckers C; Michaux JL; Verwilghen R; Sokal G Scand J Haematol; 1982 Nov; 29(5):373-80. PubMed ID: 7156888 [TBL] [Abstract][Full Text] [Related]
13. [Pathomechanism and clinical impact of myelofibrosis in neoplastic diseases of the bone marrow]. Bedekovics J; Méhes G Orv Hetil; 2014 Mar; 155(10):367-75. PubMed ID: 24583557 [TBL] [Abstract][Full Text] [Related]
14. Reversible bone marrow aplasia induced by pegylated interferon-α-2a therapy in a patient with primary myelofibrosis. Mainali NR; Bhatt VR; Kedia S; Krishnamurthy J; Wake LM; Akhtari M J Oncol Pharm Pract; 2014 Oct; 20(5):386-92. PubMed ID: 24067929 [TBL] [Abstract][Full Text] [Related]
15. Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia. Wang JC; Lang HD; Lichter S; Weinstein M; Benn P Br J Haematol; 1992 Feb; 80(2):184-8. PubMed ID: 1550774 [TBL] [Abstract][Full Text] [Related]
16. The small molecule inhibitor G6 significantly reduces bone marrow fibrosis and the mutant burden in a mouse model of Jak2-mediated myelofibrosis. Kirabo A; Park SO; Wamsley HL; Gali M; Baskin R; Reinhard MK; Zhao ZJ; Bisht KS; Keserű GM; Cogle CR; Sayeski PP Am J Pathol; 2012 Sep; 181(3):858-65. PubMed ID: 22796437 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis. Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679 [TBL] [Abstract][Full Text] [Related]
18. A distinct subtype of idiopathic myelofibrosis with bone marrow features mimicking hairy cell leukemia: evidence of an autoimmune pathogenesis. Hasselbalch H; Jans H; Nielsen PL Am J Hematol; 1987 Jun; 25(2):225-9. PubMed ID: 3605072 [TBL] [Abstract][Full Text] [Related]
19. Replacement of hematopoietic system by allogeneic stem cell transplantation in myelofibrosis patients induces rapid regression of bone marrow fibrosis. Kröger N; Kvasnicka M; Thiele J Fibrogenesis Tissue Repair; 2012; 5(Suppl 1):S25. PubMed ID: 23259545 [TBL] [Abstract][Full Text] [Related]